Celastrol sensitizes bicalutamide to enhance immunogenic Cell death in the treatment of castration-resistant prostate
Peipei Meng, He Li, Yuhang Meng, Li Dong, Guancheng Wang, Qinxin Zhao, Wei Yang, Huang Hongdong
This study shows that combining Celastrol and bicalutamide enhances cytotoxicity, apoptosis, and immunogenic cell death in castration-resistant prostate cancer.
bioRxiv · Jul 8, 2025 · PreprintCancer Biology